Colibri Seeks Full Federal Circuit Review in Medtronic Patent Case

By Editorial Team

Colibri Heart Valve LLC is pushing for a full review by the Federal Circuit in a patent case against Medtronic's CoreValve unit. The company is contesting a panel's decision that overturned a patent infringement judgment exceeding $125 million, arguing that the panel's interpretation of the law was overly broad.

Colibri's move to seek a full Federal Circuit review comes after the panel's ruling went against the company's favor. The dispute revolves around a patent related to a method of controlled release of a percutaneous replacement heart valve.

The legal battle between Colibri and Medtronic has drawn the attention of legal experts and industry observers due to the significant financial stakes involved and the potential implications for patent law.

Law360, a leading legal news platform, has been closely following the developments in this case, providing in-depth analysis and coverage of the legal arguments put forth by both parties.

Legal experts anticipate that the outcome of this case could have far-reaching consequences for patent disputes in the medical device industry and may set important precedents for future cases.

For more detailed information on the case, including court documents and related legal proceedings, interested parties can access the attached petition and additional case information available through Law360's comprehensive legal database.